Location History:
- Nazareth, BE (1999 - 2002)
- Nazareth-Eke, BE (1998 - 2016)
Company Filing History:
7 out of 43 
6 out of 82 
2 out of 3 
Years Active: 1998-2016
Title: The Innovative Contributions of Eugeen Vanmechelen
Introduction
Eugeen Vanmechelen is a prominent inventor based in Nazareth-Eke, Belgium. He has made significant contributions to the field of neurodegeneration, particularly in the development of antibodies for tau-related diseases. With a total of 17 patents to his name, Vanmechelen's work has had a profound impact on medical research and diagnostics.
Latest Patents
One of his latest patents involves the development of antibodies to phosphorylated tau aggregates. This invention focuses on affinity tools for oligomeric forms of tau protein, which are crucial in understanding tau-related diseases and tauopathy. The patent provides novel tau antibodies and antibody fragments, along with nucleic acids encoding these antibodies. It also includes cell lines that produce such antibodies, compositions for detecting aggregated tau, and kits for diagnosing diseases associated with aggregated tau. Furthermore, the invention outlines methods for detecting aggregated tau and identifying compositions that interfere with the formation and stability of tau aggregates.
Another significant patent by Vanmechelen is related to antibodies specific to β-amyloid peptides. This monoclonal antibody specifically binds to the N-terminal region of the Aβ peptide, demonstrating high affinity and specificity. This invention has potential applications as diagnostic agents or drugs in the treatment of diseases related to β-amyloid peptides.
Career Highlights
Eugeen Vanmechelen has worked with notable companies in the biotechnology sector, including Innogenetics S.A. and Innogenetics N.V. His career has been marked by a commitment to advancing research in neurodegenerative diseases through innovative solutions.
Collaborations
Throughout his career, Vanmechelen has collaborated with esteemed colleagues, including Marc Vandermeeren and Marc Mercken. These collaborations have further enriched his research and contributed to the development of groundbreaking inventions in the field.
Conclusion
Eugeen Vanmechelen's contributions to the field of neurodegeneration through his innovative patents and collaborations have established him as a key figure in medical research. His work continues to pave the way for advancements in the diagnosis and treatment of tau-related diseases.